Definitive Healthcare Corp expected to post earnings of 8 cents a share - Earnings Preview

Definitive Healthcare

03/05/2024 23:15

* Definitive Healthcare Corp  DH.OQ   DH.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 7 for
the period ending March 31 2024
    * The Framingham Massachusetts-based  company is expected to
report a 8.1% increase in revenue to $63.991 million from $59.2
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Definitive Healthcare
Corp is
for earnings of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Definitive
Healthcare Corp is $10.25​, above​ its last closing price
of $6.99. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.08        0.08       0.07      Missed  -8.4
 Sep. 30 2023  0.07        0.06       0.09      Beat    49.1
 Jun. 30 2023  0.06        0.06       0.08      Beat    44.6​
 Mar. 31 2023  0.05        0.04       0.06      Beat    35
 ​​Dec.        0.04        0.04       0.07      Beat    67.7
 31 2022                                                
 Jan. 1 0001   0.05        0.05       0.06      Beat    27.7​
 Jun. 30 2022  0.05        0.05       0.06      Beat    18.3
 Mar. 31 2022  0.03        0.03       0.05      Beat    44.9
 This summary was machine generated May 3 at 22:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)